ConductScience.org, home

Paper6561067

Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.

Nardelli B and 5 others. Cancer Immunol Immunother, 1984. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. Papers, record 6561067. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6561067

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2024-04-26
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nardelli BB
2Contessa ARA R
3Romani LL
4Sava GG
5Nisi CC
6Fioretti MCM C

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
DacarbazineMajor topic
Leukemia L1210Major topic
TriazenesMajor topic
Animals
Histocompatibility
Male
Mice
Neoplasm Transplantation

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11260759Drug-mediated immunogenic changes of virus-induced leukemia in vivo.Cancer Res1976https://conductscience.org/library/papers/1260759PubMed
27310657Influence of serum albumins on decomposition rates of para-substituted 1-phenyl-3-methyltriazenes and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide in near physiological conditions.J Pharm Sci1981https://conductscience.org/library/papers/7310657PubMed
34405250Synthesis of biologically active triazenes from isolable diazoniums salts.Z Naturforsch B Anorg Chem Org Chem Biochem Biophys Biol1972https://conductscience.org/library/papers/4405250PubMed
57116350Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.Cancer Treat Rep1982https://conductscience.org/library/papers/7116350PubMed
66581361Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity.J Natl Cancer Inst1983https://conductscience.org/library/papers/6581361PubMed
74402275Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.Cancer Res1972https://conductscience.org/library/papers/4402275PubMed
86821551Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo.J Immunopharmacol1980https://conductscience.org/library/papers/6821551PubMed
10146282Growth and rejection patterns of murine lymphoma cells antigenically altered following drug treatment in vivo.Transplantation1978https://conductscience.org/library/papers/146282PubMed
117016315In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.Cancer Res1981https://conductscience.org/library/papers/7016315PubMed
1292180Viral xenogenization of intact tumor cells.Adv Cancer Res1979https://conductscience.org/library/papers/92180PubMed
13379331Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity study.J Med Chem1979https://conductscience.org/library/papers/379331PubMed
144823450The use of new methods to measure: the effect of diet and inducers of microsomal enzyme synthesis on cytochrome P-450 in liver homogenates, and on metabolism of dimethyl nitrosamine.Biochem Pharmacol1974https://conductscience.org/library/papers/4823450PubMed
156928222Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.J Natl Cancer Inst1980https://conductscience.org/library/papers/6928222PubMed
16494379In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.Transplantation1979https://conductscience.org/library/papers/494379PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
34639014Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?Int J Mol Sci2021https://conductscience.org/library/papers/34639014PubMed
6566603Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6566603PubMed
3359559Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3359559PubMed
3297373Chemical xenogenization of experimental tumors.Cancer Metastasis Rev1987https://conductscience.org/library/papers/3297373PubMed
2956985Immunogenic capacity of tum--variants isolated from a rat rhabdomyosarcoma.Br J Cancer1987https://conductscience.org/library/papers/2956985PubMed
2924449Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative.Clin Exp Metastasis1989https://conductscience.org/library/papers/2924449PubMed
2470506Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2470506PubMed
2013112Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/2013112PubMed
1537073O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.Cancer Chemother Pharmacol1992https://conductscience.org/library/papers/1537073PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6561067

GET https://conductscience.org/api/papers/v1/6561067/authors